Morris v. AstraZeneca Pharmaceuticals LP et al
Filing
11
ORDER DIRECTING defendant AstraZeneca to file its Rule 7.1 corporate disclosure statement within 10 days. However, as this date would fall on a holiday, Defendant shall file said statement no later than 11/29/10. Signed by Chief Judge David R. Herndon on 11/15/10. (seg)
<![CDATA[
-PMF Morris v. AstraZeneca Pharmaceuticals LP et al
Doc. 11
IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS
DANA MORRIS, Plaintiff, v. ASTRAZENECA PHARMACEUTICALS, LP and MEGAN DEFRAIN, Defendants. ORDER HERNDON, Chief Judge: Case No. 10-cv-56-DRH
This matter comes before the Court for case management purposes, in particular to remind defendant AstraZeneca Pharmaceuticals, LP, of its obligation to comply with the requirements of FEDERAL RULE OF CIVIL PROCEDURE 7.1 by filing a corporate disclosure statement. Thus, the Court ORDERS Defendant to file its disclosure statement within ten (10) days from the date of issuance of this Order.
IT IS SO ORDERED. Signed this 15th day of November, 2010.
David R. Herndon 2010.11.15 15:07:11 -06'00'
Chief Judge United States District Court
Dockets.Justia.com
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
